The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...

The endothelium, the cellular layer lining the body’s blood vessels, is extremely resilient. Measuring just a few hundred nanometers in thickness, this super-tenuous structure routinely withstands ...

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

Welcome from the Director and Program Overview Welcome to the website of the Harvard/MIT MD-PhD Program! We believe that physician-scientist training here at Harvard and MIT provides a remarkable ...

“Fly-fishers,” he said, “are usually brain-workers in society. Along the banks of purling streams, beneath the shadows of umbrageous trees, or in the secluded nooks of charming lakes, they have ever ...

Many people with autism spectrum disorders also experience unusual gastrointestinal inflammation, but thus far scientists have not established whether and how those conditions might be linked. Now, ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...